ConductScience.org, home

Paper8175136

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

Heathcote EJ and 9 others. Hepatology, 1994. Cited by 373 papers, by iCite.

Cite this record

ConductScience Library. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Papers, record 8175136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8175136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
PubMed
Journal
Hepatology
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
373
iCite
Relative citation ratio, by iCite
12.1
iCite
Revised in PubMed
2013-11-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heathcote EJE J
2Cauch-Dudek KK
3Walker VV
4Bailey RJR J
5Blendis LML M
6Ghent CNC N
7Michieletti PP
8Minuk GYG Y
9Pappas SCS C
10Scully LJL J

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver Cirrhosis, BiliaryMajor topic
Ursodeoxycholic AcidMajor topic
Adult
Aged
Aged, 80 and over
Alkaline Phosphatase
Bilirubin
Canada
Cholestasis
Cholesterol
Double-Blind Method
Female
Follow-Up Studies
Humans
Immunoglobulin M
Male
Middle Aged
Transaminases

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00006168Ursodiol-Methotrexate for Primary Biliary CirrhosisBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by95

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 373 citations.

PMIDTitleJournalYearIn PapersSource
41868880Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis.Ann Gastroenterol2026https://conductscience.org/library/papers/41868880PubMed
41251604Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database.J Comp Eff Res2025https://conductscience.org/library/papers/41251604PubMed
41103433Impact of the prognostic nutritional index on the recompensation of patients with decompensated primary biliary cholangitis.Front Immunol2025https://conductscience.org/library/papers/41103433PubMed
40977287Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis.Aliment Pharmacol Ther2026https://conductscience.org/library/papers/40977287PubMed
40682413Pathogenesis, Non-Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases.Liver Int2025https://conductscience.org/library/papers/40682413PubMed
40672002Cost-Effectiveness of S-Adenosyl-L-Methionine for Intrahepatic Cholestasis in the United Arab Emirates.Cureus2025https://conductscience.org/library/papers/40672002PubMed
40646392The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine.Clin Rev Allergy Immunol2025https://conductscience.org/library/papers/40646392PubMed
40568038Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology.World J Gastrointest Pathophysiol2025https://conductscience.org/library/papers/40568038PubMed
40545045The history and future of bile acid therapies.J Hepatol2025https://conductscience.org/library/papers/40545045PubMed
40115760Bile acid therapy for primary biliary cholangitis: Pathogenetic validation.World J Exp Med2025https://conductscience.org/library/papers/40115760PubMed
39728045Up-to-Date Snapshot of Current and Emerging Medical Therapies in Primary Biliary Cholangitis.J Pers Med2024https://conductscience.org/library/papers/39728045PubMed
38178006Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment.BMC Gastroenterol2024https://conductscience.org/library/papers/38178006PubMed
36388729Management of biliary stones in bariatric surgery.Ther Adv Gastrointest Endosc2022https://conductscience.org/library/papers/36388729PubMed
36339545Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis.Front Pharmacol2022https://conductscience.org/library/papers/36339545PubMed
34007800Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis.J Clin Transl Hepatol2021https://conductscience.org/library/papers/34007800PubMed
32861449Recent developments in diagnostics and treatment of neonatal cholestasis.Semin Pediatr Surg2020https://conductscience.org/library/papers/32861449PubMed
32039371New treatments/targets for primary biliary cholangitis.JHEP Rep2019https://conductscience.org/library/papers/32039371PubMed
31762074
Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
Aliment Pharmacol Ther2020https://conductscience.org/library/papers/31762074PubMed
30903105Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics.Nat Rev Gastroenterol Hepatol2019https://conductscience.org/library/papers/30903105PubMed
30862662Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells.EMBO Mol Med2019https://conductscience.org/library/papers/30862662PubMed

See all 95 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8175136

GET https://conductscience.org/api/papers/v1/8175136/cited_by?page=2